From: Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation
Patient | Coronary artery size before PE (mm) | Coronary artery size after PE (mm) | Coronary artery size 1 year after treatment (mm) |
---|---|---|---|
1 | RCA 6.9 LMT 5.0 LAD 4.0 LCx 3.6 | RCA 13.1 LMT 6.9 LAD 7.0 LCx 7.0 | RCA 4.9 |
2 | RCA 3.3 LAD 4.1 | Regression | Regression |
3 | RCA 3.6 LAD 3.4 | RCA 5.0 LAD 5.6 | RCA 5.9 LAD 5.1 |
4 | RCA 4.1 LAD 4.9 | RCA 3.4 LAD 4.4 | Regression |
5 | RCA 3.1 | Regression | Regression |
6 | LMT 4.3 | LMT 4.7 | Regression |
7 | RCA 3.1 | RCA 3.0 | Regression |
8 | RCA 3.0 LMT 3.2 LAD 3.0 | RCA 4.4 LMT 3.5 LAD 5.0 | Regression |
9 | RCA 15.1 LMT 3.5 LAD 18.2 | Death due to ruptured coronary artery aneurysm | – |
10 | RCA 4.3 LMT 3.5 LAD 4.5 | RCA 6.6 LAD 7.5 | RCA 5.5 LAD 6.0 |